Innovative Grade US Origin Wistar Rat Complement Serum Reference 6-28-14

Posted by Leanne Kodsman on

Innovative Research's Innovative Grade US Origin Wistar Rat Complement Serum was recently used in the following study:

Inhibitor (s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica

J Ratelade, AS Verkman - Molecular Immunology, 2014
We conclude that mice have limited utility as models of NMO. 2. Materials and methods. 2.1. Reagents and antibodies. Complement/sera from mouse (CD1 and C57BL/6 strains), rat (Wistar strain), guinea pig and human were purchased from Innovative Research (Novi, MI).

  • Tags: Animal Serum, Innovative Grade US Origin Rat Wistar Complement Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer
    Single Donor Human Whole Blood from Innovative Research was used in the following study...
    Read the Article
    Measurement of Thrombolysis Enhanced by EkoSonic Catheter-Based Endovascular Therapy
    Pooled Human Plasma Apheresis Derived from Innovative Research was used in the followin...
    Read the Article
    The Role of Type I Interferons in TLR7-Mediated Lupus and UVB-Induced Immune Cell Responses
    Mouse IgG ELIS A Kit from Innovative Research was used in the following study:   The R...
    Read the Article

    ← Older Post Newer Post →